CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Capecitabine
Related studies linked through entity extraction aliases.
Phase II Clinical Study on the Efficacy and Safety of the Combination of Cadonilimab and Capecitabine in Adjuvant Therapy for Combined Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- Status
- RECRUITING
- Phase
- PHASE2
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC
- Status
- RECRUITING
- Phase
- PHASE3
Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- NA
Adaptive Immunotherapy for Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE3
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
- Status
- RECRUITING
- Phase
- PHASE2
Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Anti-EGFR Agents in Patients With Right-sided Advanced Colorectal Cancer With Wild-type RAS and AREG/EREG High Status
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Node-Sparing Short-Course Radiation Combined With Capecitabine and PD-1/CTLA-4 for MSS Early Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2